Advertisement
Noel J. Guillama, President & CEO of The Quantum Group commented, "We arevery pleased that all proposals presented before the shareholders wereapproved and by the opportunity to present our recently deployed PWeR(TM)system following the conclusion of the Annual Meeting."
Advertisement
About The Quantum Group, Inc.
The Quantum Group provides business process solutions, service chainmanagement, strategic consulting and leading edge technology innovations tothe healthcare industry.
Through our dynamic patient-centric architecture, we empower thecommunication that is critical for the coordination of care and take aim atthe $600 billion inefficiency gap in the United States healthcare industry. Weare guided by a mission to develop efficiencies, improve the quality ofpatient care and achieve cost reductions for the nation's largest and fastestgrowing industry.
We have developed leading-edge technology with the creation and deploymentof a series of innovative patent-pending initiatives. Through approximately2,000 healthcare providers and multiple insurance company relationships undermanagement, we are positioned to be a catalyst for change to the Floridahealthcare industry.
Certain statements contained in this news release, which are not based onhistorical facts, are forward-looking statements as the term is defined in thePrivate Securities Litigation Reform Act of 1995, and are subject tosubstantial uncertainties and risks in part detailed in the respectivecompany's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-Kfilings (and amendments thereto) that may cause actual results to materiallydiffer from projections. Forward-looking statements can be identified by theuse of words such as "expects," "plans," "will," "may," "anticipates,""believes," "should," "intends," "estimates" and other words of similarmeaning. These statements are subject to risks and uncertainties that cannotbe predicted or quantified and, consequently, actual results may differmaterially from those expressed or implied by these forward-lookingstatements. Such risk factors include, without limitation, the ability of theCompany to properly execute its business model, to raise substantial andimmediate additional capital to implement its business model, to attract andretain executive, management and operational personnel, to execute additionalcontracts with payers, to expand the CHS network, to negotiate favorablecurrent debt and future capital raises, to negotiate favorable agreements witha diversified provider base and to continue to supply the services needed byits HMO clients as well as physician clients. The Company does not undertakeany obligation to publicly update any forward-looking statements. There canbe no assurance that the provisional patents discussed in this press releasewill be granted by the US Patent and Trademark Office, or, if they aregranted, they will not be challenged by third parties, or if not that we willbe able to effectively use or commercialize such patents and/or we may nothave the resources to deploy such technology. As a result, investors shouldnot place undue reliance on these forward-looking statements.FOR MORE I
